124 related articles for article (PubMed ID: 38244896)
1. Lipoprotein-mimicking nanotherapeutics reconstituted with chenodeoxycholic acid modified protein for efficient tumor targeting.
Hu Y; Zou J; Wang Q; Chen Y; Wang H; Li J
Eur J Pharm Biopharm; 2024 Mar; 196():114184. PubMed ID: 38244896
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
3. Mimic Lipoproteins Responsive to Intratumoral pH and Allosteric Enzyme for Efficient Tumor Therapy.
Li J; Wang H; Xu J; Wu S; Han M; Li J; Wang Q; Ge Z
ACS Appl Mater Interfaces; 2022 Jan; 14(1):404-416. PubMed ID: 34962752
[TBL] [Abstract][Full Text] [Related]
4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
[TBL] [Abstract][Full Text] [Related]
7. Lysosome-Independent Intracellular Drug/Gene Codelivery by Lipoprotein-Derived Nanovector for Synergistic Apoptosis-Inducing Cancer-Targeted Therapy.
Wang W; Chen K; Su Y; Zhang J; Li M; Zhou J
Biomacromolecules; 2018 Feb; 19(2):438-448. PubMed ID: 29334216
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
[TBL] [Abstract][Full Text] [Related]
9. Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.
Wang J; Jia J; Liu J; He H; Zhang W; Li Z
Drug Deliv; 2013 Nov; 20(8):356-63. PubMed ID: 24079327
[TBL] [Abstract][Full Text] [Related]
10. Dual-functional bio-derived nanoparticulates for apoptotic antitumor therapy.
Ding Y; Wang Y; Opoku-Damoah Y; Wang C; Shen L; Yin L; Zhou J
Biomaterials; 2015 Dec; 72():90-103. PubMed ID: 26344366
[TBL] [Abstract][Full Text] [Related]
11. A Biocompatible Reconstituted High-Density Lipoprotein Nano-System as a Probe for Lung Cancer Detection.
Lu H; Zhang H; Zhang D; Lu H; Ma D
Med Sci Monit; 2015 Sep; 21():2726-33. PubMed ID: 26365043
[TBL] [Abstract][Full Text] [Related]
12. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein-biomimetic nanocarriers for glioblastoma-targeting delivery: the effect of shape.
Huang JL; Jiang G; Song QX; Gu X; Song HH; Wang XL; Jiang D; Kang T; Feng XY; Jiang XG; Chen HZ; Gao XL
Pharmazie; 2016 Dec; 71(12):709-714. PubMed ID: 29441999
[TBL] [Abstract][Full Text] [Related]
14. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
[TBL] [Abstract][Full Text] [Related]
15. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
[TBL] [Abstract][Full Text] [Related]
16. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.
Rui M; Xin Y; Li R; Ge Y; Feng C; Xu X
Mol Pharm; 2017 Jan; 14(1):107-123. PubMed ID: 27982602
[TBL] [Abstract][Full Text] [Related]
17. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
[TBL] [Abstract][Full Text] [Related]
18. Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells.
Li J; Han M; Li J; Ge Z; Wang Q; Zhou K; Yin X
Drug Deliv; 2020 Dec; 27(1):530-541. PubMed ID: 32241173
[TBL] [Abstract][Full Text] [Related]
19. A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy.
Zhang F; Li M; Su Y; Zhou J; Wang W
Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():208-218. PubMed ID: 27127046
[TBL] [Abstract][Full Text] [Related]
20. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy.
Mei Y; Tang L; Xiao Q; Zhang Z; Zhang Z; Zang J; Zhou J; Wang Y; Wang W; Ren M
J Mater Chem B; 2021 Jan; 9(3):612-633. PubMed ID: 33306079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]